Loading...
XETR
EVK
Market cap7.05bUSD
Dec 05, Last price  
13.00EUR
1D
1.33%
1Q
-19.25%
Jan 2017
-54.19%
IPO
-59.63%
Name

Evonik Industries

Chart & Performance

D1W1MN
XETR:EVK chart
P/E
27.29
P/S
0.40
EPS
0.48
Div Yield, %
9.00%
Shrs. gr., 5y
Rev. gr., 5y
2.95%
Revenues
15.16b
-0.72%
14,125,000,00014,430,000,00015,873,000,00013,076,000,00013,300,000,00014,540,000,00013,629,000,00012,874,000,00012,917,000,00013,507,000,00012,732,000,00014,419,000,00015,024,000,00013,108,000,00012,199,000,00014,955,000,00018,488,000,00015,267,000,00015,157,000,000
Net income
222m
P
1,046,000,000876,000,000285,000,000240,000,000734,000,0001,011,000,0001,164,000,0002,054,000,000568,000,000991,000,000844,000,000717,000,000932,000,000774,000,000465,000,000746,000,000540,000,000-465,000,000222,000,000
CFO
1.71b
+7.47%
1,142,000,0001,215,000,000388,000,0002,092,000,0002,075,000,0001,309,000,0001,420,000,0001,083,000,0001,066,000,0001,971,000,0001,758,000,0001,551,000,0001,704,000,0001,321,000,0001,727,000,0001,815,000,0001,650,000,0001,594,000,0001,713,000,000
Dividend
May 29, 20250 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Evonik Industries AG engages in the specialty chemicals business. It operates through Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure segments. The Specialty Additives segment provides polyurethane additives, organically modified silicones, isophorones, epoxy curing agents, oil additives, fumed silicas, matting agents, TAA and TAA derivatives, and acetylenic diol-based surfactants for consumer goods and specialized industrial applications. The Nutrition & Care segment offers amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare products. The Smart Materials segment provides hydrogen peroxide, peracetic acid, activated nickel catalysts, precious metal powder catalysts, oil and fat hydrogenation catalysts, amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, and precipitated silicas for the automotive, paints, coatings, adhesives, construction, and various other sectors. The Performance Materials segment produces polymer materials and intermediates, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbent for rubber, plastics, and automotive industries. The Technology & Infrastructure segment provides site management, utilities and waste management, technical, process technology, engineering, and logistics services. It operates in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. The company was founded in 1873 and is headquartered in Essen, Germany. Evonik Industries AG is a subsidiary of RAG-Stiftung.
IPO date
May 01, 2013
Employees
33,357
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT